Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) — New Haven, Connecticut

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Prostate Cancer Metastatic, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale-New Haven Hospital-Yale Cancer Center ( Site 0064)?

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) conducted?

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) has 2 clinical trials on record, with 2 currently active. Their work covers Prostate Cancer Metastatic, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Is Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) accredited by Crixeo Health?

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale-New Haven Hospital-Yale Cancer Center ( Site 0064)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.